| Literature DB >> 28061778 |
Mohammad Shoaib1, Ismail Shah1, Niaz Ali2, Achyut Adhikari3, Muhammad Nawaz Tahir4, Syed Wadood Ali Shah1, Saiqa Ishtiaq5, Jahangir Khan1, Shahzeb Khan1, Mohammad Naveed Umer6.
Abstract
BACKGROUND: Sesquiterpene lactones (STLs) make a diverse and huge group of bio-active constituents that have been isolated from several plant families. However, the greatest numbers are present in Asteraceae family having more than 3000 different reported structures. Recently several researchers have reported that STLs have significant antioxidant and anticancer potentials.Entities:
Keywords: 3 T3; ABTS; Anticancer; Artemisia macrocephala; DPPH; HeLa; MCF-7; Sesquiterpene lactone
Mesh:
Substances:
Year: 2017 PMID: 28061778 PMCID: PMC5219761 DOI: 10.1186/s12906-016-1517-y
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Fig. 1a ORTEP view of the title molecule with 50% probability, b conformation of rings and orientations of methyl substitutions
Fig. 2c Formation of dimer via C-H•••O and C-H•••C intermolecular interactions, d molecular packing of compound like zig-zag pattern along a-axis
Fig. 3e Hirshfeld surface fingerprint plot, and (f) the dnorm surface of title molecule
Fig. 4g The proportion of H•••H, (h) O•••H, and (i) C•••H contacts in title molecule
Fig. 5Percentage contributions to the Hirshfeld surface areas for the various intermolecular contacts (H/H, O/H and C/H) in molecule
Percent DPPH radical scavenging activity of STL
| 25 | 50 | 75 | 100 | 125 | 150 | |
|---|---|---|---|---|---|---|
| Ascorbic acid | 67.33 ± 0.41 | 73 ± 0.61 | 77.26 ± 0.68 | 83.09 ± 0.42 | 87.11 ± 0.87 | 88.68 ± 0.58 |
| Tocopherol | 71.32 ± 0.36 | 78.16 ± 0.57 | 85.41 ± 0.61 | 91.18 ± 0.53 | 93.24 ± 0.75 | 94.33 ± 0.49 |
| Rutin | 78.03 ± 0.76 | 84.11 ± 0.43 | 86.63 ± 0.81 | 92.25 ± 0.61 | 94.35 ± 0.66 | 96.67 ± 0.51 |
| STL | 26.65 ± 1.04 | 31.62 ± 0.67 | 40.94 ± 0.63 | 47.63 ± 0.39 | 54.74 ± 0.86 | 68.76 ± 0.82 |
Percent ABTS radical scavenging activity of STL
| 25 | 50 | 75 | 100 | 125 | 150 | |
|---|---|---|---|---|---|---|
| Ascorbic acid | 70.23 ± 0.41 | 77.56 0.61 | 80.26 ± 0.68 | 85.09 ± 0.42 | 87.61 ± 0.87 | 89.88 ± 0.58 |
| Tocopherol | 74.32 ± 0.36 | 78.16 ± 0.57 | 86.41 ± 0.61 | 91.18 ± 0.53 | 93.84 ± 0.75 | 94.33 ± 0.49 |
| Rutin | 79.03 ± 0.76 | 85.11 ± 0.43 | 87.63 ± 0.81 | 89.25 ± 0.61 | 92.35 ± 0.66 | 94.67 ± 0.51 |
| STL | 30.65 ± 1.04 | 33.62 ± 0.67 | 42.94 ± 0.63 | 45.63 ± 0.39 | 61.74 ± 0.86 | 71.76 ± 0.82 |
In-Vitro anti-proliferative activity (% cell growth inhibition) of STL against 3 T3, HeLa and MCF-7 cell lines
| Sample | Concentration | 3 T3 | HeLa | MCF-7 |
|---|---|---|---|---|
| STL | 1000 | 43.11 ± 1.34 | 81.25 ± 3.07 | 73.41 ± 2.11 |
| 500 | 28.25 ± 2.00 | 64.39 ± 2.40 | 65.34 ± 2.00 | |
| 250 | 21.91 ± 1.05 | 53.56 ± 2.00 | 49.62 ± 2.32 | |
| 125 | 15.00 ± 0.52 | 37.58 ± 1.78 | 35.50 ± 1.00 | |
| 62.5 | 09.25 ± 1.56 | 24.67 ± 1.65 | 27.50 ± 0.85 |
Acetic acid induced writhing response of pure compounds
| Treatment/Dose | Number of writhing | % inhibition |
|---|---|---|
| Control (2% Tween 80) | 69.75 ± 1.45 | --- |
| Diclofenac sodium (10 mg) | 11.65 ± 2.02 | 83.29 |
| Ism-1 25 mg | 54.66 ± 1.20* | 21.63 |
| 32.35 ± 1.35** | 53.62 |
All the values were expressed as mean ± SEM (n = 6). * P < 0.1, ** P < 0.01 when compared to control group (one way ANOVA followed by Dunnetts: compare all vs control test)
Formalin-induced paw-licking response of pure compounds
| Treatment/Dose | Licking time (Sec) | Inhibition (%) | ||
|---|---|---|---|---|
| 1st Phase | 2nd Phase | 1st Phase | 2nd Phase | |
| Control (2% Tween 80) | 51.85 ± 1.83 | 73.05 ± 1.75 | ---- | ---- |
| Morphine 5 mg | 7.01 ± 1.153*** | 3.05 ± 1.290*** | 86.48 | 95.82 |
| Indomethacin 10 mg | 37.35 ± 1.37** | 19.38 ± 1.440*** | 27.69 | 73.47 |
| Ism-1 25 mg | 32.45 ± 1.231* | 41.12 ± 1.204* | 37.41 | 43.70 |
| 28.43 ± 1.356** | 35.45 ± 1.198** | 45.16 | 51.47 | |
All the values were expressed as mean ± SEM (n = 6). * P < 0.1, ** P < 0.01 and *** P < 0.001 when compared to control group (one way ANOVA followed by Dunnetts: compare all vs control test)
Tail flick response of isolated compounds
| Treatment/Dose | Time in Sec (Tail Flick)/Response (%) | |||||
|---|---|---|---|---|---|---|
| 15 min | 30 min | 45 min | 60 min | 75 min | 90 min | |
| Control | 0.79 ± 0.017 | 0.87 ± 0.033 | 0.99 ± 0.024 | 0.94 ± 0.036 | 0.87 ± 0.029 | 0.90 ± 0.048 |
| Ism-1 25 mg | 0.95 ± 1.12* | 1.07 ± 0.112* | 1.30 ± 0.131** | 1.33 ± 0.124** | 1.33 ± 0.163*** | 1.33 ± 0.138*** |
| 0.98 ± 1.20 | 1.11 ± 0.411* | 1.34 ± 0.161** | 1.37 ± 0.201** | 1.38 ± 0.206*** | 1.36 ± 0.218*** | |
| Standard (M) | 1.20 ± 0.024 | 2.03 ± 0.066 | 3.89 ± 0.038 | 6.30 ± 0.054 | 4.40 ± 0.050 | 4.30 ± 0.074 |
| N + 1 25 mg | 0.93 ± 0.045 | 0.94 ± 0.043 | 1.10 ± 0.052 | 0.99 ± 0.052 | 0.90 ± 0.058 | 0.93 ± 0.096 |
| 0.89 ± 0.039 | 0.95 ± 0.068 | 1.50 ± 0.064 | 0.99 ± 0.047 | 0.89 ± 0.080 | 0.95 ± 0.089 | |
| M + N | 0.80 ± 0.046 | 0.87 ± 0.037 | 0.94 ± 0.045 | 0.91 ± 0.033 | 0.91 ± 0.034 | 0.91 ± 0.045 |
All the values were expressed as mean ± SEM (n = 6). * P < 0.05, ** P < 0.01 and *** P < 0.001 when compared to control group (one way ANOVA followed by Dunnetts: compared all vs control test)
Key: M Morphine 5 mg, N Naloxone 2 mg